Shots:
- Cencora & Covetrus have entered into a definitive agreement to merge Covetrus with MWI Animal Health, forming a unified company delivering a comprehensive animal health platform
- The deal values MWI at a $3.5B enterprise value, with Cencora receiving $1.25B in cash, $800M in preferred equity, & $1.45B in common equity, securing a 34.3% non-controlling stake in the combined company upon closing
- Combined company will enhance animal health access & affordability, and support innovation by expanding product reach, adoption, & improved care across companion and large animal markets
Ref: Businesswire | Image: MWI Animal Health | Press Release
Related News: PRN Pharmacal Receives the Full US FDA Approval for KBroVet to Control Seizures in Dogs with Idiopathic Epilepsy
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
